Araştırma Makalesi
BibTex RIS Kaynak Göster

Is Elderly-Onset Rheumatoid Arthritis Different From Younger-Onset Rheumatoid Arthritis?

Yıl 2022, , 243 - 250, 30.06.2022
https://doi.org/10.34087/cbusbed.1032757

Öz

Objectives: To compare elderly-onset rheumatoid arthritis (EORA) patients with younger-onset rheumatoid arthritis (YORA) patients in terms of sociodemographic, clinical and radiological features, and treatment responses.
Materials and Methods: 422 rheumatoid arthritis (RA) patients were evaluated retrospectively. Patients with the age of onset of disease symptoms ≥60 were considered EORA, and those <60 were considered YORA. Sociodemographic characteristics, co-morbid diseases, laboratory values,joint involvement patterns, accompanying extra-articular findings,Simple Erosion Narrowing radiological scores(SENS) and the number of patients meeting the 1987 American College of Rheumatology-Rheumatoid Arthritis(ACR-RA) classification criteria were evaluated at the time of initial diagnosis.The doses of steroids and disease-modifying anti-rheumatic drugs(DMARDs) were recorded. Disease activity score with erythrocyte sedimentation rate (DAS28-ESR) at the beginning and 3rd month of DMARDs treatment were recorded.
Results: The frequency of EORA was 8.3%.The frequency of rheumatoid factor positivity(82.9%), co-morbid disease frequency(77.1%) and the mean value of erythrocyte sedimentation rate (62.0±25.21 mm/h) seen in patients with EORA were significantly higher than patients with YORA(55%,%19.9 and 33.97±19.48, respectively)(p<0.05).There was no significant difference between patients with EORA and patients with YORA in terms of the baseline DAS-28-ESR and C-reactive protein mean values,SENS median value,frequency of positive anti-cyclic citrullinated peptide,joint involvement frequency, frequency of meeting 1987 ACR-RA classification criteria, and frequency of steroid and DMARDs usage(p>0.05).There was no difference between the patients with EORA and YORA in terms of DAS28-ESR values measured at the 3rd month of treatment and steroid doses used(p>0.05).
Conclusion: There is no difference in many clinical and laboratory findings, especially disease activity scores and radiographic scores, in patients with EORA and YORA.

Kaynakça

  • Ozer PK, Sahin O, Ozer Z, Cengiz AK, Durmaz Y, Kaptanoglu E. Ultrasound-defined remission for good functional status in rheumatoid arthritis. Indian J Med Res 2017; 146: 230-6.
  • Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int 2017; 37: 1551-7.
  • Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010; 62: 1576-82.
  • Laiho K, Tuomilehto J, Tilvis R. Prevalence of rheumatoid arthritis and musculoskeletal diseases in the elderly population. Rheumatol Int 2001; 20: 85-7.
  • Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 2003; 48: 917-26.
  • Villa-Blanco JI, Calvo-Alén J. Elderly Onset Rheumatoid Arthritis. Drugs & Aging 2009; 26: 739-50.
  • Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994; 33: 735-9.
  • Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
  • Gensler LS. Glucocorticoids: complications to anticipate and prevent. Neurohospitalist 2013; 3: 92-7.
  • van der Heijde D, Dankert T, Nieman F, Rau R, Boers M. Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 941-7.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
  • Hair J BW, Babin B, Anderson R, Tatham R. Multivariate Data Analysis. Essex, England. In: Pearson Education Limited; 2013.
  • Richter MD, Matteson EL, Davis JM, 3rd, Achenbach SJ, Crowson CS. Comparison of Biologic Discontinuation in Patients With Elderly-Onset Versus Younger-Onset Rheumatoid Arthritis. ACR Open Rheumatol 2019; 1: 627-31.
  • Calvo-Alén J, Corrales A, Sánchez-Andrada S, Fernández-Echevarría MA, Peña JL, Rodríguez-Valverde V. Outcome of late-onset rheumatoid arthritis. Clin Rheumatol 2005; 24: 485-9.
  • Krams T, Ruyssen-Witrand A, Nigon D, Degboe Y, Tobon G, Fautrel B, et al. Effect of age at rheumatoid arthritis onset on clinical, radiographic, and functional outcomes: The ESPOIR cohort. Joint Bone Spine 2016; 83: 511-5.
  • Cho SK, Sung YK, Choi CB, Cha HS, Choe JY, Chung WT, et al. Do patients with elderly-onset rheumatoid arthritis have severe functional disability? Semin Arthritis Rheum 2012; 42: 23-31.
  • Turkcapar N, Demir O, Atli T, Kopuk M, Turgay M, Kinikli G, et al. Late onset rheumatoid arthritis: clinical and laboratory comparisons with younger onset patients. Arch Gerontol Geriatr 2006; 42: 225-31.
  • El-Labban AS, Omar HA, El-Shereif RR, Ali F, El-Mansoury TM. Pattern of Young and Old Onset Rheumatoid Arthritis (YORA and EORA) Among a Group of Egyptian Patients with Rheumatoid Arthritis. Clin Med Insights Arthritis Musculoskelet Disord 2010; 3: 25-31.
  • Tamas MM, Felea I, Rednic S. How much difference does the age at onset make in early arthritis patients? Comparison between the ACR 1987 and the ACR/EULAR 2010 classification criteria for rheumatoid arthritis at the time of diagnosis. Rheumatol Int 2013; 33: 2881-4.
  • Terkeltaub R, Esdaile J, Décary F, Tannenbaum H. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. J Rheumatol 1983; 10: 418-24.
  • Deal CL, Meenan RF, Goldenberg DL, Anderson JJ, Sack B, Pastan RS, et al. The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum 1985; 28: 987-94.
  • Lance NJ, Curran JJ. Late-onset, seropositive, erosive rheumatoid arthritis. Semin Arthritis Rheum 1993; 23: 177-82.
  • Chen DY, Hsieh TY, Chen YM, Hsieh CW, Lan JL, Lin FJ. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease. Gerontology 2009; 55: 250-8.
  • Takeda T. [Treatment strategy of elderly rheumatoid arthritis]. Nihon Rinsho Meneki Gakkai Kaishi 2016; 39: 497-504.

Yaşlı Başlangıçlı Romatoid Artrit, Genç Başlangıçlı Romatoid Artritten Farklı mı?

Yıl 2022, , 243 - 250, 30.06.2022
https://doi.org/10.34087/cbusbed.1032757

Öz

Giriş ve Amaç: Yaşlı başlangıçlı romatoid artritli (YBRA) hastaları, genç başlangıçlı romatoid artritli (GBRA) hastalar ile sosyodemografik, klinik, radyolojik ve tedavi yanıtları açısından karşılaştırmaktır.
Gereç ve Yöntemler: 2010 American College of Rheumatology-Rheumatoid Arthritis (ACR-RA) sınıflama kriterlerini karşılayan 422 romatoid artrit (RA) hastası geriye dönük olarak değerlendirildi. Hastalık semptomlarının başlangıç yaşı≥60 olan hastalar YBRA, <60 olanlar GBRA olarak kabul edildi. Sosyodemografik özellikler, komorbid hastalıklar, laboratuvar değerleri, eklem tutulum paternleri, eşlik eden eklem dışı bulgular, radyolojik skorlar ve 1987 ACR-RA sınıflama kriterlerini karşılayan hasta sayısı ilk tanı anında belirlendi. Steroid ve hastalık modifiye edici antiromatizmal ilaçların(HMEAİ) dozları kaydedildi. HMEAİ tedavisinin başlangıcında ve 3. ayında hastalık aktivite skoru(DAS28-ESR) incelendi.
Bulgular: YBRA sıklığı %8,3 idi. YBRA’li hastalarda romatoid faktör pozitiflik sıklığı (%82.9),komorbid hastalık sıklığı (%77.1) ve eritrosit sedimantasyon hızı ortalama değeri (62.0±25.21 mm/saat) GBRA’li hastalardan anlamlı derecede yüksekti (sırasıyla %55,%19.9 ve 33.97±19.48)(p<0.05). YBRA'lı hastalar ile GBRA'lı hastalar arasında; başlangıç DAS-28-ESR değerleri, C-reaktif protein ortalama değerleri, SENS medyan değeri, anti-siklik sitrüline peptid pozitiflik sıklığı, eklem tutulum patern sıklıkları, 1987 ACR-RA sınıflandırma kriterlerini karşılayan hasta sıklığı ve steroid ile HMEAİ kullanım sıklığı açısından anlamlı farklılık yoktu (p>0.05). Yine YBRA ve GBRA'lı hastalar arasında tedavinin 3. ayında ölçülen DAS28-ESR değerleri ve kullanılan steroid dozları açısından farklılık yoktu (p>0.05).
Sonuç: YBRA ve GBRA'lı hastalarda hastalık aktivite skorları ve radyografik skorlar başta olmak üzere birçok klinik ve laboratuvar bulgu arasında farklılık yoktur.

Kaynakça

  • Ozer PK, Sahin O, Ozer Z, Cengiz AK, Durmaz Y, Kaptanoglu E. Ultrasound-defined remission for good functional status in rheumatoid arthritis. Indian J Med Res 2017; 146: 230-6.
  • Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int 2017; 37: 1551-7.
  • Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010; 62: 1576-82.
  • Laiho K, Tuomilehto J, Tilvis R. Prevalence of rheumatoid arthritis and musculoskeletal diseases in the elderly population. Rheumatol Int 2001; 20: 85-7.
  • Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 2003; 48: 917-26.
  • Villa-Blanco JI, Calvo-Alén J. Elderly Onset Rheumatoid Arthritis. Drugs & Aging 2009; 26: 739-50.
  • Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ. The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 1994; 33: 735-9.
  • Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
  • Gensler LS. Glucocorticoids: complications to anticipate and prevent. Neurohospitalist 2013; 3: 92-7.
  • van der Heijde D, Dankert T, Nieman F, Rau R, Boers M. Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology (Oxford) 1999; 38: 941-7.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
  • Hair J BW, Babin B, Anderson R, Tatham R. Multivariate Data Analysis. Essex, England. In: Pearson Education Limited; 2013.
  • Richter MD, Matteson EL, Davis JM, 3rd, Achenbach SJ, Crowson CS. Comparison of Biologic Discontinuation in Patients With Elderly-Onset Versus Younger-Onset Rheumatoid Arthritis. ACR Open Rheumatol 2019; 1: 627-31.
  • Calvo-Alén J, Corrales A, Sánchez-Andrada S, Fernández-Echevarría MA, Peña JL, Rodríguez-Valverde V. Outcome of late-onset rheumatoid arthritis. Clin Rheumatol 2005; 24: 485-9.
  • Krams T, Ruyssen-Witrand A, Nigon D, Degboe Y, Tobon G, Fautrel B, et al. Effect of age at rheumatoid arthritis onset on clinical, radiographic, and functional outcomes: The ESPOIR cohort. Joint Bone Spine 2016; 83: 511-5.
  • Cho SK, Sung YK, Choi CB, Cha HS, Choe JY, Chung WT, et al. Do patients with elderly-onset rheumatoid arthritis have severe functional disability? Semin Arthritis Rheum 2012; 42: 23-31.
  • Turkcapar N, Demir O, Atli T, Kopuk M, Turgay M, Kinikli G, et al. Late onset rheumatoid arthritis: clinical and laboratory comparisons with younger onset patients. Arch Gerontol Geriatr 2006; 42: 225-31.
  • El-Labban AS, Omar HA, El-Shereif RR, Ali F, El-Mansoury TM. Pattern of Young and Old Onset Rheumatoid Arthritis (YORA and EORA) Among a Group of Egyptian Patients with Rheumatoid Arthritis. Clin Med Insights Arthritis Musculoskelet Disord 2010; 3: 25-31.
  • Tamas MM, Felea I, Rednic S. How much difference does the age at onset make in early arthritis patients? Comparison between the ACR 1987 and the ACR/EULAR 2010 classification criteria for rheumatoid arthritis at the time of diagnosis. Rheumatol Int 2013; 33: 2881-4.
  • Terkeltaub R, Esdaile J, Décary F, Tannenbaum H. A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. J Rheumatol 1983; 10: 418-24.
  • Deal CL, Meenan RF, Goldenberg DL, Anderson JJ, Sack B, Pastan RS, et al. The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration. Arthritis Rheum 1985; 28: 987-94.
  • Lance NJ, Curran JJ. Late-onset, seropositive, erosive rheumatoid arthritis. Semin Arthritis Rheum 1993; 23: 177-82.
  • Chen DY, Hsieh TY, Chen YM, Hsieh CW, Lan JL, Lin FJ. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease. Gerontology 2009; 55: 250-8.
  • Takeda T. [Treatment strategy of elderly rheumatoid arthritis]. Nihon Rinsho Meneki Gakkai Kaishi 2016; 39: 497-504.
Toplam 24 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Romatoloji ve Artrit
Bölüm Araştırma Makalesi
Yazarlar

Yunus Durmaz 0000-0002-1727-0088

İlker İlhanlı 0000-0002-7998-8992

Betul Ustun Cetinkaya Bu kişi benim 0000-0002-8694-5181

Kıvanç Cengiz 0000-0002-4390-7169

Yayımlanma Tarihi 30 Haziran 2022
Yayımlandığı Sayı Yıl 2022

Kaynak Göster

APA Durmaz, Y., İlhanlı, İ., Ustun Cetinkaya, B., Cengiz, K. (2022). Is Elderly-Onset Rheumatoid Arthritis Different From Younger-Onset Rheumatoid Arthritis?. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 9(2), 243-250. https://doi.org/10.34087/cbusbed.1032757
AMA Durmaz Y, İlhanlı İ, Ustun Cetinkaya B, Cengiz K. Is Elderly-Onset Rheumatoid Arthritis Different From Younger-Onset Rheumatoid Arthritis?. CBU-SBED. Haziran 2022;9(2):243-250. doi:10.34087/cbusbed.1032757
Chicago Durmaz, Yunus, İlker İlhanlı, Betul Ustun Cetinkaya, ve Kıvanç Cengiz. “Is Elderly-Onset Rheumatoid Arthritis Different From Younger-Onset Rheumatoid Arthritis?”. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 9, sy. 2 (Haziran 2022): 243-50. https://doi.org/10.34087/cbusbed.1032757.
EndNote Durmaz Y, İlhanlı İ, Ustun Cetinkaya B, Cengiz K (01 Haziran 2022) Is Elderly-Onset Rheumatoid Arthritis Different From Younger-Onset Rheumatoid Arthritis?. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 9 2 243–250.
IEEE Y. Durmaz, İ. İlhanlı, B. Ustun Cetinkaya, ve K. Cengiz, “Is Elderly-Onset Rheumatoid Arthritis Different From Younger-Onset Rheumatoid Arthritis?”, CBU-SBED, c. 9, sy. 2, ss. 243–250, 2022, doi: 10.34087/cbusbed.1032757.
ISNAD Durmaz, Yunus vd. “Is Elderly-Onset Rheumatoid Arthritis Different From Younger-Onset Rheumatoid Arthritis?”. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 9/2 (Haziran 2022), 243-250. https://doi.org/10.34087/cbusbed.1032757.
JAMA Durmaz Y, İlhanlı İ, Ustun Cetinkaya B, Cengiz K. Is Elderly-Onset Rheumatoid Arthritis Different From Younger-Onset Rheumatoid Arthritis?. CBU-SBED. 2022;9:243–250.
MLA Durmaz, Yunus vd. “Is Elderly-Onset Rheumatoid Arthritis Different From Younger-Onset Rheumatoid Arthritis?”. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, c. 9, sy. 2, 2022, ss. 243-50, doi:10.34087/cbusbed.1032757.
Vancouver Durmaz Y, İlhanlı İ, Ustun Cetinkaya B, Cengiz K. Is Elderly-Onset Rheumatoid Arthritis Different From Younger-Onset Rheumatoid Arthritis?. CBU-SBED. 2022;9(2):243-50.